These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36615466)

  • 1. Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments.
    Giorgi E; Binacchi F; Marotta C; Cirri D; Gabbiani C; Pratesi A
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria as a target of third row transition metal-based anticancer complexes.
    Olelewe C; Awuah SG
    Curr Opin Chem Biol; 2023 Feb; 72():102235. PubMed ID: 36516614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azaindoles: Suitable ligands of cytotoxic transition metal complexes.
    Štarha P; Trávníček Z
    J Inorg Biochem; 2019 Aug; 197():110695. PubMed ID: 31054487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases.
    Lu Y; Ma X; Chang X; Liang Z; Lv L; Shan M; Lu Q; Wen Z; Gust R; Liu W
    Chem Soc Rev; 2022 Jul; 51(13):5518-5556. PubMed ID: 35699475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinage metal complexes against breast cancer.
    Biersack B; Ahmad A; Sarkar FH; Schobert R
    Curr Med Chem; 2012; 19(23):3949-56. PubMed ID: 22780959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.
    Silva MJSA; Gois PMP; Gasser G
    Chembiochem; 2021 May; 22(10):1740-1742. PubMed ID: 33507625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms.
    Njenga LW; Mbugua SN; Odhiambo RA; Onani MO
    Dalton Trans; 2023 May; 52(18):5823-5847. PubMed ID: 37021641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New applications of old metal-binding drugs in the treatment of human cancer.
    Schmitt SM; Frezza M; Dou QP
    Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents.
    Steinbrueck A; Sedgwick AC; Brewster JT; Yan KC; Shang Y; Knoll DM; Vargas-Zúñiga GI; He XP; Tian H; Sessler JL
    Chem Soc Rev; 2020 Jun; 49(12):3726-3747. PubMed ID: 32525153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy.
    Li ZY; Shen QH; Mao ZW; Tan CP
    Chem Asian J; 2022 Jul; 17(13):e202200270. PubMed ID: 35419865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallo-Drugs in Cancer Therapy: Past, Present and Future.
    Lucaciu RL; Hangan AC; Sevastre B; Oprean LS
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Natural Product-Conjugated Metal Complexes as Cancer Therapies.
    Ma DL; Wu C; Cheng SS; Lee FW; Han QB; Leung CH
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30650627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progresses in TCM metal-based antitumour agents.
    Chen ZF; Liang H
    Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fresh platinum complexes with promising antitumor activity.
    Wang X
    Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies.
    Palermo G; Magistrato A; Riedel T; von Erlach T; Davey CA; Dyson PJ; Rothlisberger U
    ChemMedChem; 2016 Jun; 11(12):1199-210. PubMed ID: 26634638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speciation of precious metal anti-cancer complexes by NMR spectroscopy.
    Zou T; Sadler PJ
    Drug Discov Today Technol; 2015 Sep; 16():7-15. PubMed ID: 26547416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.